Abiomed to expand its medical device manufacturing in Ireland

Published: 7-Aug-2008

Abiomed Inc in the US has signed a long-term operating lease for a medical device manufacturing facility in Athlone, Ireland.


Abiomed, headquartered in Danvers, Massachusetts, expects to begin facility preparations immediately and currently anticipates that the first production line for its intra-aortic balloon pump, the Impella 2.5 Cardiac Assist Device, will be operational in approximately 18 months.

Abiomed's capacity expansion plans in Ireland are intended to meet anticipated long-term demand for the cardiac assist device and augment capacity from the company's Aachen, Germany facility.

In June 2008, Abiomed announced that it had received US Food and Drug Administration 510(k) clearance for its Impella 2.5 that allows the company to begin selling the device to the estimated 14,000 interventional cardiologists at approximately 1,700 heart hospitals in the US.

The company has signed a long-term operating lease on an Athlone facility formerly occupied by Conor Medsystems.

"We are excited to announce our capacity expansion plans to meet anticipated long-term demand for our Impella 2.5 device," said Michael R. Minogue, chairman, ceo and president of Abiomed. "We chose this Ireland location because it simply met our primary criteria - a great building with existing cleanroom space, a great workforce, a strong supplier network and the financial and cash investments are within our previously budgeted Fiscal Year 2009 plan."

The company announced that the Ireland facility has a total of 33,000 sq ft of space including approximately 10,000 sq ft of finished cleanroom space.

The company indicated that the longer-term plans for the Ireland facility will be to designate Ireland as Abiomed's global centre of excellence for high-volume disposable products manufacturing including the Impella 2.5 and the extended Impella product line of the Impella 5.0, right percutaneous and Impella pediatric products and other circulatory care disposable products that Abiomed may offer in the future.

See more

You may also like

Analysis

The case for a facility monitoring system

Read more
In regulated manufacturing, monitoring environmental conditions and critical equipment is essential to protect product quality, yield, and patient safety. Facilities often use a Facility Monitoring System (FMS) to track factors like airborne particles, temperature, and humidity. Beyond regulatory compliance, FMS delivers real business value through reduced waste, improved yield, higher quality, and greater profitability

Trending Articles

  1. AdvanceTEC drives cleanroom innovation & growth with acquisition by Equans Leveraging scale, global reach, technology, prefabrication & modularisation
  2. Medicinal cannabis production with GMP-compliant cleanroom solutions Controlled environments are supporting quality, safety and regulatory compliance in cannabis manufacturing
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    President Trump signs order for “regulatory relief” for domestic pharmaceutical manufacturers The US President has signed an executive order to direct the FDA to review current regulatory procedures, such as by reducing inspection frequency
  4. Pharmaceutical carbon reduction expert EECO2 achieves B Corp status A relatively unique certification in the cleanroom design industry, EECO2 has been determined to meet the necessary high standards of social and environmental performance, transparency, and accountability for B Corporation status
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Integrating “high-voltage leak detection” into automated visual inspection Leoni Ransmann and Jan Sende from Syntegon Technology talk about visual inspection of product containers like ampoules, which has been the industry standard for decades, and compare it to modern methods being emphasised in documents like the new EU GMP Annex 1

Upcoming event

Cleanzone Middle East

September 18-19 2025 | Conference | Conrad Dubai, United Arab Emirates See all

You may also like

Analysis

The case for a facility monitoring system

In regulated manufacturing, monitoring environmental conditions and critical equipment is essential to protect product quality, yield, and patient safety. Facilities often use a Facility Monitoring System (FMS) to track factors like airborne particles, temperature, and humidity. Beyond regulatory compliance, FMS delivers real business value through reduced waste, improved yield, higher quality, and greater profitability
Pharmaceutical

300 hours of performance with APSPG-Max

NewAge Industries, Inc., parent company of the AdvantaPure™ line of tubing, hose and quality accessories for the high-purity market, announces the launch of its’ newest line of tubing, AdvantaSil APSPG-Max silicone pump tubing
Design & Build

Kemtile to showcase single source flooring solutions at PPMA 2025

Kemtile is using PPMA 2025 to engage prospective customers on the benefits of coming to an internationally-backed industrial flooring and drainage business with a single source approach to flooring projects across the process and packaging industry
Pharmaceutical

Steriline at CPHI 2025

Flexibility, robotics and customisation for a zero loss approach
Design & Build

AdvanceTEC drives cleanroom innovation & growth with acquisition by Equans

Leveraging scale, global reach, technology, prefabrication & modularisation
Pharmaceutical

Steriline at Pharma Pro&Pack Expo 2025

With its own branch already established in India, Steriline confirms the importance of the Indian and of Asian markets in general for its growth and development
Design & Build

Preserve and protect your cleanroom with a Guardtech Group Cleanroom Service Plan

Suffolk-based construction experts offering elite packages to ensure all service, maintenance and decontamination needs are taken care of
Subscribe now